From: Polymorphism in asparagine synthetase is associated with overall survival of hepatocellular carcinoma patients
Haplotypes
HCC (n = 337)
CHB (n = 310)
P
OR (95%CI)
A-G
520.76(0.773)
508.74(0.821)
0.09
0.79(0.60–1.04)
A-T
96.24(0.143)
62.26(0.100)
0.02
1.52(1.08–2.13)
T-G
42.24(0.063)
44.26(0.071)
0.58
0.88(0.57–1.37)
T-Ta
14.76(0.022)
4.74(0.008)